SMCO1: Protein Involved in Intracellular Signaling, DNA Replication and Gene Expression

Target Name: SMCO1

NCBI ID: G255798

SMCO1

SMCO1: Protein Involved in Intracellular Signaling, DNA Replication and Gene Expression

SMCO1 (SMCO1_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, and kidneys. It is a member of the superfamily of coat-cased proteins, which include proteins that are involved in various cellular processes , including intracellular signaling, DNA replication, and gene expression.

SMCO1 is characterized by its unique structure, which consists of a long coiled region and a short transmembrane region. The coiled region of SMCO1 is composed of a series of alternating beta-helices, which give the protein its characteristic \"coiled\" appearance. The transmembrane region of SMCO1 contains a single transmembrane alpha-helix that is responsible for the protein's ability to interact with various cellular signaling pathways.

SMCO1 is involved in a number of different cellular processes, including intracellular signaling, DNA replication, and gene expression. One of the ways that SMCO1 is involved in intracellular signaling is through its role in the regulation of the production of signaling proteins. For example, SMCO1 has been shown to play a role in the regulation of the production of the protein PDGF-R2, which is involved in the development and maintenance of tissues.

SMCO1 is also involved in the regulation of DNA replication. In fact, SMCO1 has been shown to play a role in the regulation of DNA replication in various cell types, including neurons and immune cells. This is because SMCO1 is involved in the formation of a protein complex that is responsible for ensuring the proper organization and initiation of DNA replication.

In addition to its role in intracellular signaling and DNA replication, SMCO1 is also involved in the regulation of gene expression. This is because SMCO1 is a component of the machinery that is responsible for regulating the translation of RNA into proteins. By interacting with the protein RNA-binding protein (RBP), SMCO1 is able to regulate the translation of RNA into various proteins, including signaling proteins, cytoskeletal proteins, and enzymes.

SMCO1 is also a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, SMCO1 has been shown to be involved in the regulation of the growth and survival of cancer cells, which makes it a potential target for cancer therapies. In addition, SMCO1 has also been shown to be involved in the regulation of the development and progression of neurodegenerative diseases, which makes it a potential target for neurodegenerative therapies.

SMCO1 is also a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, SMCO1 has been shown to be involved in the regulation of the growth and survival of cancer cells, which could make it a potential biomarker for cancer. In addition, SMCO1 has also been shown to be involved in the regulation of the development and progression of neurodegenerative diseases, which could make it a potential biomarker for neurodegenerative diseases.

In conclusion, SMCO1 is a protein that is involved in various cellular processes, including intracellular signaling, DNA replication, and gene expression. It is characterized by its unique structure, which consists of a long coiled region and a short transmembrane region. SMCO1 is involved in the regulation of the production of signaling proteins, DNA replication, and gene expression, and it is a potential drug target and biomarker for various diseases. Further research is needed to fully understand the role of SMCO1 in cellular processes and its potential as a drug target and biomarker.

Protein Name: Single-pass Membrane Protein With Coiled-coil Domains 1

The "SMCO1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SMCO1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets